673 related articles for article (PubMed ID: 34470666)
21. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E
Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226
[TBL] [Abstract][Full Text] [Related]
22. Transcriptomic Differences between Primary Colorectal Adenocarcinomas and Distant Metastases Reveal Metastatic Colorectal Cancer Subtypes.
Kamal Y; Schmit SL; Hoehn HJ; Amos CI; Frost HR
Cancer Res; 2019 Aug; 79(16):4227-4241. PubMed ID: 31239274
[TBL] [Abstract][Full Text] [Related]
23. Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer.
Cavallaro P; Bordeianou L; Stafford C; Clark J; Berger D; Cusack J; Kunitake H; Francone T; Ricciardi R
Clin Colorectal Cancer; 2020 Mar; 19(1):e8-e17. PubMed ID: 31899147
[TBL] [Abstract][Full Text] [Related]
24. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.
Pitroda SP; Khodarev NN; Huang L; Uppal A; Wightman SC; Ganai S; Joseph N; Pitt J; Brown M; Forde M; Mangold K; Xue L; Weber C; Segal JP; Kadri S; Stack ME; Khan S; Paty P; Kaul K; Andrade J; White KP; Talamonti M; Posner MC; Hellman S; Weichselbaum RR
Nat Commun; 2018 May; 9(1):1793. PubMed ID: 29728604
[TBL] [Abstract][Full Text] [Related]
25. Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.
Jackstadt R; van Hooff SR; Leach JD; Cortes-Lavaud X; Lohuis JO; Ridgway RA; Wouters VM; Roper J; Kendall TJ; Roxburgh CS; Horgan PG; Nixon C; Nourse C; Gunzer M; Clark W; Hedley A; Yilmaz OH; Rashid M; Bailey P; Biankin AV; Campbell AD; Adams DJ; Barry ST; Steele CW; Medema JP; Sansom OJ
Cancer Cell; 2019 Sep; 36(3):319-336.e7. PubMed ID: 31526760
[TBL] [Abstract][Full Text] [Related]
26. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
[TBL] [Abstract][Full Text] [Related]
27. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
[TBL] [Abstract][Full Text] [Related]
28. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
[TBL] [Abstract][Full Text] [Related]
29. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum.
Varghese S; Burness M; Xu H; Beresnev T; Pingpank J; Alexander HR
Ann Surg Oncol; 2007 Dec; 14(12):3460-71. PubMed ID: 17899288
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP
Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355
[TBL] [Abstract][Full Text] [Related]
31. Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma.
Roessler S; Lin G; Forgues M; Budhu A; Hoover S; Simpson RM; Wu X; He P; Qin LX; Tang ZY; Ye QH; Wang XW
Int J Biol Sci; 2015; 11(1):88-98. PubMed ID: 25552933
[TBL] [Abstract][Full Text] [Related]
32. Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer.
Joung JG; Oh BY; Hong HK; Al-Khalidi H; Al-Alem F; Lee HO; Bae JS; Kim J; Cha HU; Alotaibi M; Cho YB; Hassanain M; Park WY; Lee WY
Clin Cancer Res; 2017 Dec; 23(23):7209-7216. PubMed ID: 28939741
[No Abstract] [Full Text] [Related]
33. Tropism between hepatic and pulmonary metastases in colorectal cancers.
Kim SH; Choi SJ; Park JS; Lee J; Cho YB; Kang MW; Lee WY; Choi YS; Kim HK; Han J; Chun HK; Kim J
Oncol Rep; 2012 Aug; 28(2):459-64. PubMed ID: 22664832
[TBL] [Abstract][Full Text] [Related]
34. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
[TBL] [Abstract][Full Text] [Related]
35. Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases.
Yuzhalin AE; Lim SY; Gordon-Weeks AN; Fischer R; Kessler BM; Yu D; Muschel RJ
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G625-G639. PubMed ID: 31545917
[TBL] [Abstract][Full Text] [Related]
36. EGFR expression variance in paired colorectal cancer primary and metastatic tumors.
Yarom N; Marginean C; Moyana T; Gorn-Hondermann I; Birnboim HC; Marginean H; Auer RC; Vickers M; Asmis TR; Maroun J; Jonker D
Cancer Biol Ther; 2010 Sep; 10(5):416-21. PubMed ID: 20595818
[TBL] [Abstract][Full Text] [Related]
37. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K
Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers.
Kleist B; Meurer T; Poetsch M
Tumour Biol; 2017 Mar; 39(3):1010428317692246. PubMed ID: 28345467
[TBL] [Abstract][Full Text] [Related]
39. Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases.
Wood CS; Pennel KAF; Leslie H; Legrini A; Cameron AJ; Melissourgou-Syka L; Quinn JA; van Wyk HC; Hay J; Roseweir AK; Nixon C; Roxburgh CSD; McMillan DC; Biankin AV; Sansom OJ; Horgan PG; Edwards J; Steele CW; Jamieson NB
Cancer Res; 2023 Apr; 83(8):1329-1344. PubMed ID: 37057593
[TBL] [Abstract][Full Text] [Related]
40. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
